ACQUIRED · 2023
Who Acquired AngioDynamics Dialysis Product Portfolio and BioSentry Product?
Merit Medical Systems, Inc. · $100.0M
The acquisition
AngioDynamics Dialysis Product Portfolio and BioSentry Product was acquired by Merit Medical Systems, Inc. in 2023 for $100.0M. at 3.10× revenue.
AngioDynamics Dialysis Product Portfolio and BioSentry Product at time of acquisition
Revenue
$32.0M
Deal value
$100.0M
Other acquisitions by Merit Medical Systems, Inc.
Recent transactions by the same buyer — useful for understanding their playbook and what they typically pay.
- Cook Medical Pacemaker / ICD Lead Management Portfolio · 2024 · $210.0M
- EndoGastric Solutions EsophyX Z+ · 2024 · $105.0M
- Avanos Medical Respiratory Business · 2023 · $110.0M
Similar medical devices acquisitions
- Owen Mumford Holdings · acquired by Embecta in 2026 · $201.0M
- Acera Surgical · acquired by Solventum in 2025 · $725.0M
- Alydia Health (Organon JADA System) · acquired by Laborie Medical Technologies in 2025 · $440.0M
- B Medical Systems (Azenta) · acquired by THELEMA S.A. R.L. in 2025 · $63.0M
- BIOTRONIK Vascular Intervention Business · acquired by Teleflex, Inc. in 2025 · $875.9M
Run a valuation for a similar medical devices business
Three fields, instant range, backed by 25,592 real M&A transactions including this one.
Open the medical devices calculator →More on medical devices valuations
- Medical Devices valuation calculator· head-term variant
- Medical Devices median multiples· real-deal benchmarks
- How to value a medical devices· long-form guide
Sourced from Press releases. Full deal page.
Citation: ExitValue.ai. (2023). AngioDynamics Dialysis Product Portfolio and BioSentry Product acquired by Merit Medical Systems, Inc.. https://exitvalue.ai/acquired/angiodynamics-dialysis-product-portfolio-and-biosentry-product